Dermatology Times' Weekly Crossword: SDPA Summer Edition

Welcome to Dermatology Times' Sunday Crossword, where dermatology knowledge meets fun! Each week, we curate a selection of words and terms pulled directly from the latest news in the dermatology world. Whether it's breakthrough treatments, new research findings, or emerging trends, this crossword serves as both a challenge and an opportunity to reinforce your expertise in the field.

This week, we are spotlighting all the best clinical pearls and expert insights from this past week's Society of Dermatology Physician Associates (SDPA) Annual Summer Dermatology Conference in Washington, DC. For the past 4 days, Dermatology Times has been providing coverage of the meeting. To view all coverage, visit our SDPA conference coverage page.

To sign up to receive daily email updates from live meetings and to keep up to date with the latest in coverage from the conference, subscribe to our email newsletters here.

Try out either our interactive crossword or a static/non-interactive version below.

Interactive Crossword

This crossword was created with CrosswordLabs.com.

Static/Non-Interactive Crossword

Across

3. Amy Spizuoco, DO, FAOCD, presented on how this technique supports hair loss diagnosis.

8. This talk series spotlighted leadership, advocacy, and industry CV reviews for PAs.

10. A color wheel method was shared to improve diagnostic confidence in this visual diagnostic tool.

13. Sally Santos, PhD, PA-C, covered advanced cosmetic techniques including the use of these injectable agents.

14. Cynthia Griffith, MPAS, PA-C, discussed career-building and publication opportunities through this journal.

16. Janelle Ball offered strategies to improve success with these time-consuming insurance requirements.

18. Eileen Cheever, MPAS, PA-C, led a session that highlighted facts about this family of intracellular signaling proteins.

Down

1. This IL-36 receptor inhibitor showed durable results in a high-risk patient with GPP.

2. This oral PDE4 inhibitor showed efficacy across BMI spectrums for early oligoarticular PsA.

4. DFD-29 outperformed doxycycline in this inflammatory facial condition.

5. An evening symposium explored clinical insights and management strategies for this pigmentary disorder.

6. These cosmetic injectables were part of a session on basics to advanced dermatologic techniques.

7. “Fear No Hives” shared new insights into spontaneous chronic forms of this itchy condition.

9. Skin signs led to the early detection of this serious cancer progression.

11. Several tracks, including “Behind the Flare,” explored this science behind chronic inflammatory diseases.

12. Spesolimab and TYK2 inhibitors were among the therapies highlighted for this chronic disease.

15. Adam Friedman, MD, FAAD, emphasized a stepwise approach to treating chronic eczema located here.

17. This kinase target is associated with next-generation treatments for plaque psoriasis.

For answers to this week's puzzle, check out next week's edition of the Dermatology Times Sunday Crossword.

Answers from our June 22, 2025 puzzle: [Across: 4 - NV-UVB; 8 - alopecia; 9 - eczema; 12 - IL17; 13 - infant; 14 - inclusive; 15 - ruxolitinib; 16 - tattoo; Down: 1 - upadacitinib; 2 - ritlecitinib; 3 - roflumilast; 5 - vitiligo; 6 - CHE; 7 - depression; 11 - SkinGPT]